The bacterial ribosome and its associated translation factors are frequent targets of antibiotics, and antibiotic resistance mutations have been found in a number of these components. Such mutations can potentially interact with one another in unpredictable ways, including the phenotypic suppression of one mutation by another. These phenotypic interactions can provide evidence of long-range functional interactions throughout the ribosome and its functional complexes and potentially give insights into antibiotic resistance mechanisms. In this study, we used genetics and experimental evolution of the thermophilic bacterium Thermus thermophilus to examine the ability of mutations in various components of the protein synthesis apparatus to suppress the streptomycin resistance phenotypes of mutations in ribosomal protein S12, specifically those located distant from the streptomycin binding site. With genetic selections and strain constructions, we identified suppressor mutations in EF-Tu or in ribosomal protein L11. Using experimental evolution, we identified amino acid substitutions in EF-Tu or in ribosomal proteins S4, S5, L14, or L19, some of which were found to also relieve streptomycin resistance. The wide dispersal of these mutations is consistent with long-range functional interactions among components of the translational machinery and indicates that streptomycin resistance can result from the modulation of long-range conformational signals.
T
he ribosome is the highly conserved RNA-protein complex responsible for protein synthesis in all species and is the target of numerous antibiotics that bind to spatially dispersed, highly conserved functional sites (reviewed in references 1-3). Mutations arising in antibiotic binding sites often confer resistance, rendering such drugs ineffective. Given that the ribosome has multiple antibiotic binding sites, it is perhaps not surprising that mutations conferring resistance to one antibiotic can cause increased sensitivity to another. For instance, a C1066U base substitution in Escherichia coli 16S rRNA conferring spectinomycin resistance causes increased sensitivity to fusidic acid (4), while fusidic acid resistance mutations in Salmonella enterica serovar Typhimurium fusA confer hypersensitivity to multiple unrelated antibiotics, including streptomycin (5) . Resistance phenotypes also depend on previously acquired mutations or phylogenetic sequence variations. This is illustrated by Mycoplasma hominis, which is intrinsically resistant to 14-and 15-atom macrolides due to a naturally occurring G2057A variation in 23S rRNA; resistance is lost upon acquisition of a C2611U substitution selected for clindamycin resistance (6) . Alternating antibiotic treatments can constrain evolution of multidrug resistance (7) but can also favor the accumulation of multiple resistance mutations (8) . Multiple antibiotic resistance mutations can phenotypically interact with one another in an unpredictable manner. Understanding the nature of such phenotypic interactions could significantly benefit the development of more effective strategies to combat drug-resistant pathogens, while providing insights into higher-order functional interactions in the ribosome.
A particularly informative set of phenotypic interactions involves ribosomal protein S12 and elongation factor Tu (EF-Tu), and amino acid substitutions conferring resistance to streptomycin or kirromycin. Streptomycin is a bactericidal aminoglycoside that binds to the small ribosomal subunit via contacts with 16S rRNA and ribosomal protein S12 (9) . It induces misreading of the genetic code (10) by stimulating the rate at which EF-Tu hydrolyzes GTP in response to codon recognition by near-cognate tRNAs (11) . EF-Tu, in turn, is the target of several antibiotics, one of these being kirromycin, which freezes EF-Tu on the ribosome following GTP hydrolysis (reviewed in reference 12). Not surprisingly, resistance mutations arise in the binding sites for either drug. Remarkably, a kirromycin resistance (Kir r ) mutation producing an A375T (E. coli numbering used throughout) amino acid substitution in the kirromycin binding site of EF-Tu (see Fig. S1 in the supplemental material) has been found to have an antagonistic effect on the resistance phenotype of a subset of streptomycin resistance (Str r ) mutations affecting S12 (13, 14) , despite the two binding sites being separated by over 75 Å in the 70S ribosome-EF-Tu decoding complex (15) (Fig. 1) .
Phenotypic interactions between Str r and Kir r mutations can perhaps be best understood in terms of their effects on translational accuracy. Ribosomes bearing Str r mutations are generally error restrictive, or hyperaccurate, exhibiting excessive rejection of cognate tRNAs (16, 17) . Such mutations occur most frequently in rpsL, encoding ribosomal protein S12, and the most severely error-restrictive ribosomal mutation yet described is the rpsL500 allele that creates an R53L amino acid substitution (18) . Bacterial genomes generally carry two copies of the gene encoding EF-Tu, tufA and tufB. Kirromycin resistance is generally recessive, requiring mutations in both genes (19) . The rpsL500 mutation was originally selected for its ability to confer dominant Kir r to a phenotypically Kir s tufB ϩ tufA-A375T heterozygote of Salmonella Typhimurium (13) . The S. Typhimurium rpsL500 mutation on its own confers a Str r phenotype, which is suppressed by the tufA-A375T mutation; the tufA-A375T mutation on its own has an error-prone phenotype, opposite that of the rpsL500 mutation (13) . Thus, while distantly located mutations are unlikely to mutually influence the conformation of their corresponding drug binding sites, they can, as in this case, potentially influence their The structure is based on PDB entry 4DR3 (55) . (E) Relative spatial distribution of sites of mutations in the 70S ribosome bound to EF-Tu-aa-tRNA (PDB entry 4V5L [34] ). Protein C␣ atoms and RNA phosphate atoms of mutated residues are shown as spheres. Green atoms mark sites of Str r mutations in ribosomal protein S12, red atoms mark sites of mutations that relieve the Str r phenotype of certain S12 mutations, and purple atoms mark sites of mutations that relieve the S12-H76R or R37C mutations but not S12-K53E. Corresponding proteins or RNA structures are shown in gray.
phenotypes indirectly via mutually antagonistic impacts on specific steps of protein synthesis. Str r mutations affecting ribosomal protein S12 can be thought of as belonging to either of two classes, defined by their positions relative to the streptomycin binding site and thus their mechanisms of resistance. Those occurring at position K42 or K87 in the streptomycin binding site confer resistance by interfering with streptomycin-ribosome interactions (9) . In contrast, amino acid substitutions at positions R37, R53 (K53 in Thermus thermophilus), or H76 (here referred to as "noncanonical" Str r mutations) act indirectly while allowing streptomycin binding. Such mutations were originally identified in E. coli as secondary or "ancillary" mutations in combination with streptomycin dependence (Str d ) mutations in rpsL (20) . Similarly, rpsL-P90L, R37C or rpsL-P90L, H76R double mutants have been identified in Thermus thermophilus; the H76R and R37C ancillary mutations each confer a Str r phenotype independent of the P90L mutation (14) . Furthermore, an rpsL-K53E mutation was also selected directly as an Str r mutation in an otherwise wild-type genetic background. Ribosomes bearing the H76R substitution continue to bind streptomycin, consistent with the location of this residue remote from the streptomycin binding site. All three mutations are also distinct in that their Str r phenotype is suppressed by a Kir r tufB-A375T mutation, despite being 30 to 40 Å away (14) . How mutations located at such distances influence one another is unclear but has important implications for the phenotypes of multiply resistant mutants.
The observations described above indicate that it is possible to detect phenotypic interactions between widely dispersed mutations. In this study, we used three experimental approaches to identify such interactions. First we performed genetic selections for spontaneous secondary antibiotic resistance mutations and tested their effects on the Str r phenotypes of rpsL mutations. Next, we performed experimental evolution using the deleterious rpsL-K53E mutant, selecting for fitness-enhancing mutations. Finally, we introduced previously identified mutations by natural transformation and examined the loss or retention of the Str r phenotype. These experiments have allowed us to expand on our previous observations to include additional mutations in genes encoding EF-Tu as well as mutations in genes encoding ribosomal proteins S4, S5, L11, L14, and L19 and to identify those that can influence the phenotype of noncanonical Str r mutations. The vast majority of these mutations are at sites far removed from the site of the original mutation, consistent with long-range functional communication throughout the ribosome that is susceptible to interference by antibiotics.
MATERIALS AND METHODS
Bacterial strains and cultivation. All mutants were derived from the Icelandic T. thermophilus strain IB-21 (ATCC 43815) (21) and were grown in ATCC medium 1598 (Thermus enhanced medium [TEM]) at 72°C. Antibiotics were purchased from the following suppliers: streptomycin sulfate from MP Biomedicals; thiostrepton from Calbiochem; and erythromycin, paromomycin sulfate, and rifampin from Sigma. Kirromycin was a generous gift from Eric Cundliffe, University of Leicester, United Kingdom, and Michael O'Connor, University of Missouri, Kansas City.
As a comparative measure of drug sensitivity, we measured zones of growth inhibition around antibiotic-infused filter paper discs. As a control, we determined that none of the mutations alters sensitivity to other antibiotics, including erythromycin (which binds to the polypeptide exit tunnel within the 50S subunit), paromomycin (which binds to the 30S subunit at the decoding site), or rifampin (which binds to RNA polymerase).
Mutant selections. Spontaneous mutants were selected by plating ϳ10 9 cells on TEM plates with 2.8% BD Bacto agar containing streptomycin at 100 g/ml, kirromycin at 25 g/ml, and thiostrepton at 0.01 or 0.1 g/ml. Transformation with genomic DNA was performed as described by Koyama (22) . Sensitivity to streptomycin or kirromycin was determined by disc assay and measuring zones of inhibition as described previously (23) . Sensitivity to thiostrepton was determined by streaking for single colonies from overnight cultures onto TEM plates containing thiostrepton at either 0.01 or 0.05 g/ml. Genes were amplified by PCR from genomic DNA and sequenced with primers designed against the T. thermophilus HB27 genome (24) . The mutants described here were determined, by examining sequence trace files, to be homozygous for mutations in the 16S and 23S rRNA genes. In accordance with our previous report, we observed a dominant Kir r phenotype conferred by mutations in the tufB gene only (14) . All EF-Tu mutants described here have a wildtype tufA gene. The genes for ribosomal proteins S12 (rpsL), S4 (rpsD), S5 (rpsE), L11 (rplK), L14 (rplN), and L19 (rplS) are each present in single copies.
Experimental evolution and strain constructions. Evolution experiments were performed by inoculating 3 ml of TEM with a single colony, growing the colony aerobically to saturation, diluting the culture 1:1,000 into 3 ml of fresh TEM, and repeating this for a total of 30 cycles as described previously (25) . Some thiostrepton-resistant (Thi r ) mutants were constructed by transformation with genomic DNA from mutants described previously (26) . Figures were generated using PyMol (27) .
RESULTS AND DISCUSSION
Interaction of Kir r and Str r mutations. The kirromycin binding site is located at the interface between domains I and III of EF-Tu (12) (see Fig. S1 in the supplemental material), and previous studies have identified Kir r mutations at this interface (28) . These observations are consistent with the proposal that domains I and III are dynamic with respect to one another (29) . Amino acid substitutions at this interface have been found to influence the phenotype of Str r mutants (13, 14) . To examine the interaction of Kir r and Str r mutations, we identified spontaneous Kir r derivatives of Str r mutants. Among the spontaneous Kir r mutants arising in our selection, the tufB mutations A375V and R123W were each found to reverse the Str r phenotype of rpsL-H76R; in contrast, the Q124R mutation did not have this effect (Table 1, by R123W but not by the adjacent Q124R mutation may reflect a larger structural perturbation caused by the bulkier side chain substitution in the R123W mutant. It also indicates that the loss of Str r is not directly related to Kir r per se but instead may be related to conformational dynamics at the domain I-to-III interface. Additionally, we found that the Str r phenotype could be restored to the rpsL-H76R tufB-A375T double mutant by an additional tufB mutation, A367V (Table 1 , JC536, derived from JC469 by selection on streptomycin). This third mutation is located within domain III proximal to domain II and thus is also implicated in interdomain dynamics.
Experimental evolution of mutations suppressing the deleterious rpsL-K53E Str r mutation. Laboratory evolution studies have shown that deleterious fitness effects of antibiotic resistance mutations are often compensated for by secondary mutations distant from the original mutation (25, 30, 31) . Using this approach, we evolved secondary mutations that enhance the fitness of T. thermophilus bearing the rpsL-K53E allele. This approach was made possible by the growth defect imparted by the rpsL-K53E allele. We conducted a similar evolution experiment with the rpsL-H76R mutant but did not identify any compensatory mutations. Since this mutation is not as deleterious as the rpsL-K53E mutation, longer evolution timescales may be required for fitness enhancing mutations to arise. As with the rpsL-H76R mutation (14) , the Str r phenotype of the rpsL-K53E mutation is likely indirect, not affecting drug binding but compensating for the misreading induced by streptomycin. For evolution experiments, we established 19 independent lineages from single colonies of JC346 (rpsL-K53E), passaged them serially for 300 generations, and then identified fitness-enhancing mutations by sequencing genes whose products are involved in the decoding process, which is affected by streptomycin.
One evolved mutation arose in tufB, producing a D45G amino acid substitution in EF-Tu. This mutation did not affect the Str r phenotype nor did it confer Kir r ( Table 2 , JC1324). D45 of EF-Tu is located in the switch I region within the GTP-binding domain I ( Fig. 1; see Fig. S1 and S2 in the supplemental material). This part of EF-Tu is an effector modulating GTPase activity; it is highly flexible, adopting an ␣-helical conformation in the GTP-bound form and a ␤-hairpin structure in the GDP-bound form (32, 33) . In different crystal structures of ternary complex bound to the 70S ribosome, the switch I region is either ordered (34) or disordered (15) , indicating that its dynamic nature is influenced by EF-Turibosome interactions.
Evolved, non-Kir r amino acid substitutions at the interface between EF-Tu domains I and III influencing Str r . Additional rpsL-K53E evolved lineages were found to have amino acid substitutions elsewhere in EF-Tu, namely, A101V and R154W in domain I and T335A in domain III ( Fig. 1; see Fig. S1 and S2 in the supplemental material). These rpsL tufB double mutants were found to be sensitive to both streptomycin and kirromycin ( Table  2 , JC1329, JC1337, and JC1330), although JC1330 did show a reduced zone of inhibition by kirromycin in disc assays compared to the wild type, suggesting reduced sensitivity. The Kir s phenotypes of these mutants are consistent with these residues being distant from the kirromycin binding site (see Fig. S1A ). A101V could potentially affect the positioning of the P loop of EF-Tu, which protects GTP from spontaneous hydrolysis, while R154W may act more generally on the architecture of domain I, as it resides in an ␣-helix further removed from the GTP binding site. T335A is positioned near the 5= end of the tRNA and at the interface between all three domains of EF-Tu and could influence interdomain mobility.
Evolution of an intragenic fitness-enhancing mutation in protein S12. One lineage evolved from rpsL-K53E contained an 
a EF-Tu (tufB) mutants were selected with kirromycin, and L11 (rplK) and 23S rRNA (rrlAB) mutants were selected with thiostrepton. b S, sensitive; R, resistant. 
a rpsL, S12; rrsAB, 16S rRNA; rpsD, S4; rpsE, S5; rplN, L14; rplS, L19; tufB, EF-Tu. The number of lineages in which the mutation arose is indicated in parentheses. b S, sensitive; R, resistant. c Generated by gene replacement and selecting Str r and derived from an evolved mutant containing a third mutation. intragenic mutation, T63I. The rpsL-K53E, T63I evolved lineage tested streptomycin sensitive. However, the Str s phenotype must be due to a third, yet-to-be identified mutation, since the rpsL-K53E, T63I allele transformed wild-type T. thermophilus IB-21 to streptomycin resistance (Table 2, JC1375) . Based on the location of T63 adjacent to K53 in the ␤-sheet structure of S12 (Fig. 1D) , we speculate that the T63I substitution evolved to partially relieve local conformational distortion caused by the K53E substitution, without compensating for the defect in the S12-16S rRNA interaction caused by the original mutation.
We have found previously that the Str d phenotype of an rpsL-P90R strain is suppressed intragenically by the K42T substitution (35) . These residues are in two highly conserved loops of S12 that are also in close proximity to 16S rRNA helix 44, suggesting that the restoration of the conformation of S12, in supporting helix 44, may be a common driving force. Among the 19 rpsL-K53E evolved lineages, there were two wild-type revertant lineages: one lineage with tufB-D45G plus a reversion to wild-type S12 and one lineage with a fitness-enhancing mutation that could not be identified.
Amino acid substitutions in ribosomal proteins distant from the streptomycin binding site. Experimental evolution of the rpsL-K53E strain also produced secondary mutations located in distant parts of both ribosomal subunits (Table 3 ). These included amino acid substitutions in ribosomal proteins S4, S5, L14, and L19. Proteins S4 and S5 are located on the solvent side of the 30S subunit, opposite protein S12 and the streptomycin binding site (Fig. 1B) , while L14 and L19 are located on the 50S subunit (Fig.  1C) . The rpsD-A79V and rpsE-A99V substitutions in proteins S4 and S5, respectively (see Fig. S1B and S3 in the supplemental material), both suppressed the Str r phenotype of rpsL-K53E. The rplN-G50R and rplS-E33V substitutions in proteins L14 and L19, respectively, both suppressed the Str r phenotype, although the rplN-R64C substitution did not. Mutations affecting these proteins were previously identified using experimental evolution of an E. coli rpsL-K42N mutant (30, 31) . Taken together, these data indicate that there is not a direct correspondence between the Str r phenotype and the severe growth defect of the rpsL-K53E substitution mutant.
The same evolution experiment also gave rise to two base substitutions in 16S rRNA, A338G and C342A, located in helix 14 ( Fig. 1E; see Fig. S1C in the supplemental material) . Each of these mutations abolishes the Str r phenotype of the rpsL-K53E mutant, despite their distance from S12 and the streptomycin binding site ( Table 2 , JC1332 and JC1338). This helix forms part of an intersubunit bridge involving 50S ribosomal proteins L14 and L19 and is in the vicinity of the switch I region of EF-Tu (34, 36, 37) . For both mutations, gene conversion between the 16S rRNA genes rrsA and rrsB produced pure populations of mutant ribosomes. We do not know if mutations in both genes are required for improved fitness, as single mutants were not identified.
Interaction of Thi r and Str r mutations. The peptide antibiotic thiostrepton acts by binding to the GTPase-associated center (GAC) of the 50S subunit at a cleft formed by the N-terminal domain (NTD) of ribosomal protein L11 and helices 43 and 44 of 23S rRNA (38) . Resistance to thiostrepton can be conferred by base substitutions in 23S rRNA (39, 40) or amino acid substitutions in L11 (41) . While it is known primarily as an inhibitor of translocation (reviewed in reference 1), thiostrepton has also been shown to interfere with formation of a stable complex between the ribosome and EF-Tu-GTP-aminoacyl-tRNA (aa-tRNA) (42) .
Prompted by this observation together with the well-established physical interactions between the GAC and EF-Tu or aa-tRNA (15, 37, 43) , we reasoned that some mutations in the thiostrepton binding site could influence streptomycin resistance.
For each of the Str r rpsL mutants, we isolated spontaneous thiostrepton-resistant (Thi r ) derivatives or generated them by gene replacement (35) and then screened them for streptomycin sensitivity. Predictably, the spontaneous Thi r mutations arose in rplK encoding L11 or in the L11-binding region of 23S rRNA. Neither of the 23S rRNA mutations A1067G and A1095G altered the Str r phenotype of any of the S12 mutants. This may be explained by the previous observation that an A1067U mutation does not affect proofreading or decoding accuracy (44) . In contrast, several mutations in rplK (P22L, P25L, and P73L) effectively masked the Str r phenotype of rpsL-R37C (JC1295 and JC1367) and rpsL-H76R (JC1184, JC1199, and JC1366) but not rpsL-K53E nor rpsL-K42T (Table 1 ; see Fig. S2 in the supplemental material) . Importantly, Thi r mutations on their own do not affect sensitivity to streptomycin (e.g., JC1213, JC1218, and JC1362). Furthermore, the Thi r phenotypes are not affected by the Str r mutations. Thi r mutations at residues P22 and P25 are located in the NTD of L11. This region is highly flexible with respect to the C-terminal (26) . We isolated the apparently novel rplK-P73L Thi r mutation in the context of an rpsL tufB double mutant (derived from JC499 to produce JC1316 [14] ) and moved it by transformation to the rpsL mutant strains. P73 is positioned in the linker region between the two domains of L11, and this amino acid substitution could affect the mobility of the NTD.
The rplK mutations described here relieve the Str r phenotype of the rpsL-R37C and rpsL-H76R mutants but not the rpsL-K53E mutant. This distinction may be a function of the more severe functional defect caused by the rpsL-K53E allele. Consistent with previous observations, no mutations suppressed the rpsL-K42T allele, which directly inhibits streptomycin binding (14) .
Mechanisms of compensation of Str r mutations. In this study, we began with Str r mutations that are, in all probability, highly error restrictive. It has been known for some time that most Str r mutations have an error-restrictive phenotype that is largely responsible for their fitness costs (48, 49) . Because streptomycin does not act as a competitive inhibitor, some mutations can confer resistance without abolishing streptomycin binding (14) . Resistance can occur by ribosomes bypassing the error-inducing activity of the drug, leaving open a possible reversal of resistance by mutations producing an error-prone phenotype. It should be noted in this light that this mechanism does not necessitate reciprocity; in other words, the error-restrictive Str r mutations do not suppress kirromycin resistance caused by mutations that are in a position to interfere with kirromycin binding. It also suggests, as we have found, that additional error-restrictive mutations could restore the Str r phenotype by compensating for the error-prone phenotype of the Kir r mutations. To our knowledge, the identifications of the tufB-D45G mutation and the rrsAB mutations are the first genetic data indicating a functional link between the switch I of EF-Tu and helix 14, but these data are supported by findings of previous genetic studies. The first known 16S rRNA suppressor of streptomycin dependence, C1469U, is located in helix 44, where it contacts helix 14 (50) . More recently, mutations in 16S rRNA helix 14, isolated as suppressors of missense and nonsense mutations, exhibit increased misreading in vitro (51) and can relieve Str d mutations in S12 (52) . We have also identified mutations in the same vicinity (25) , selected as suppressors of the Str d phenotype (A298G and A338G) or evolved to enhance the fitness of Str r or streptomycinindependent (Str i ) mutants (A160G and A349G). The available genetic and structural data suggest that codon recognition triggers an allosteric signal between the K53 region of S12 and the switch I region of EF-Tu, via helices 44 and 14 of 16S rRNA. The K53 region of S12 is in a position to sense subtle changes in the conformation of the decoding site at the top of helix 44 , analogous to what has been proposed for the P90 region of S12 (53) . Helix 44 could serve as a rigid lever that links the decoding site (at the top) to helix 14 (toward the bottom), propagating conformational changes from the decoding site along its length to helix 14. These conformational signals may then induce a conformational change of the switch I of EF-Tu.
Implications for antibiotic resistance mutations. The observations described here reinforce conclusions reached by others that the fitness effects of antibiotic resistance mutations can be ameliorated by secondary mutations (30, 31, 54) . Our findings extend these original observations to address the extent to which compensating mutations can act antagonistically toward the resistance phenotype of the original mutation. Whether this phenomenon of suppression of drug resistance is generally applicable to mutations conferring resistance to other classes of antibiotics remains to be determined.
It is notable that here all of the suppressing amino acid substitutions appearing in EF-Tu or L11 are at or near sites that undergo conformational changes during protein synthesis. As for the bases substituted in 16S rRNA, the case is not as strong, although they are in close proximity to the switch region of EF-Tu. Thus, it may be that such suppression of drug resistance results exclusively from mutations that affect the kinetics of conformational changes important for protein synthesis.
